相关实验视频

Updated: May 6, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.3K

在活体,适应感冒的,鼻内流感疫苗后报告的不良事件

Hector S Izurieta1, Penina Haber, Robert P Wise

  • 1Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Md 20852-1448, USA. hector.izurieta@fda.hhs.gov

JAMA
|December 8, 2005
PubMed
概括

对三价活体减弱型流感疫苗 (LAIV-T) 的许可后监测没有发现意外的严重风险. 观察到过敏反应等罕见事件,并且在有过史的人群中出现了喘恶化.

更多相关视频

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay08:11

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay

Published on: September 6, 2016

20.6K
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

28.9K

相关概念视频

Vaccinations01:51

Vaccinations

Overview
44.3K
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
101